Why are you reporting this TALK?
3 yrs after COVID survival cohort study
Amos Lalpubmed.ncbi.nlm.nih.gov
to learn moreDecember 8, 2023
11 hr
Channels
DiscoveryCardiologyCOVIDDermatologyEndocrinologyGastroenterologyHematologyHepatologyNephrologyNeurologyOncologyOphthalmologyEvery DayAMDDry Eye DiseaseEyeCan: A Canadian Lens on OphthalmologyARVO 2024VISIONS 2024AAO 2023WIO 2022
Primary CarePulmonologyRheumatologyUrologyDescription
3 yrs after COVID survival cohort study